Mr. Omar Khan reports

HIGH TIDE ANNOUNCES VOTING RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

High Tide Inc. has released the voting results from its annual general and special meeting of shareholders of the company held on Aug. 11, 2026. Each nominee listed in the company's management information circular dated June 29, 2026, was elected as a director of the company.

Each of the following five nominees proposed by management was elected as a director of the company. The results of such vote were as follows.

In addition, at the meeting, shareholders approved: (i) fixing the board of directors at five; (ii) appointing Davidson & Co. LLP as the company's auditor for the ensuing year and authorizing the board to fix their compensation; and (iii) the approval of the amended and restated shareholder rights plan approved by the board on June 26, 2026. The results of such votes were as follows.

About High Tide Inc.

High Tide is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide is uniquely built around the cannabis consumer, with wholly diversified and fully integrated operations across all components of cannabis, including:

• Retail: Canna Cabana is the largest cannabis retail chain in Canada, with 229 domestic and one international location. The company's Canadian brick-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, holding a growing 12-per-cent share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD (cannabidiol) products. In 2025, the company became the first North American cannabis operator to launch a brick-and-mortar presence in Germany.
• Medical cannabis distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14-per-cent share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries, including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by The Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX-V in 2022, 2024 and 2025. High Tide was also ranked No. 1 in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023.